The stock is expected to trade near the $14 offer price minus deal risk. Monitor for regulatory approvals and stockholder vote timing. If the deal closes, there is limited upside; if it fails, the stock could drop sharply. Hedge or take profits near $14 if holding.
Price Chart
Executive Summary
Organon & Co. filed additional proxy materials in support of its pending acquisition by Sun Pharmaceutical Industries for $14.00 per share in cash, representing a 103% premium and an enterprise value of $11.75 billion. The transaction requires stockholder approval and is expected to close in early 2027.
Key Financial Metrics
Key Facts
- Acquisition price of $14.00 per share in cash, a 103% premium to Organon's closing price on April 9, 2026
- Enterprise value of $11.75 billion
- Transaction approved by both boards; expected close in early 2027
- Subject to regulatory approvals and Organon stockholder vote
- Sun Pharma will become among top 25 global pharma companies with combined revenue of $12.4 billion
Financial Impact
Offer valued at $14.00 per share, representing a 103% premium to the unaffected price of $6.89 (approximate). Total enterprise value of $11.75 billion.
Risk Factors
- Regulatory approval delays or conditions could derail the deal
- Stockholder vote may not pass if a competing bid emerges
- Termination fee provisions may limit downside but still pose risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-181874 |
| Document: 0001193125-26-181874-index-headers.html | 0001193125-26-181874 |
| Document: 0001193125-26-181874-index.html | 0001193125-26-181874 |
| Document: 0001193125-26-181874.txt | 0001193125-26-181874 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 18, 2026 10w ago | Institutional Cluster | $13.68 | awaiting T+60 | — | $13.77 (−0.69%) |
Jul 31, 2026 12w ago | 8-K | $13.55 $13.74 | ▼ −1.40% | ▲ +1.05% | $13.77 (−1.66%) |
Jul 17, 2026 14w ago | 8-K | $13.49 $13.77 | ▲ +2.08% | ▼ −2.76% | $13.77 (+2.11%) |
Jun 17, 2026 18w ago | DEFM14A | $13.42 $13.64 | ▲ +1.64% | ▼ −1.51% | $13.77 (+2.65%) |
Jun 11, 2026 19w ago | DEFA14A | $13.45 $13.78 | ▲ +2.45% | ▼ −1.94% | $13.77 (+2.42%) |
Jun 1, 2026 21w ago | PREM14A | $13.37 $13.75 | ▲ +2.84% | ▲ +1.87% | $13.77 (+3.07%) |
Apr 30, 2026 25w ago | DEFA14A | $13.25 $13.52 | ▲ +2.08% | ▼ −0.74% | $13.77 (+4.00%) |
Apr 30, 2026 25w ago | 8-K | $13.25 $13.52 | ▼ −2.08% | ▲ +0.74% | $13.77 (−4.00%) |
Apr 27, 2026 26w ago | DEFA14A | $13.32 $13.56 | ▲ +1.84% | ▼ −1.88% | $13.77 (+3.45%) |
Apr 27, 2026 26w ago | DEFA14A | $13.32 $13.56 | ▲ +1.84% | ▼ −1.88% | $13.77 (+3.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers